A detailed history of Lido Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Lido Advisors, LLC holds 15,165 shares of INCY stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,165
Previous 13,529 12.09%
Holding current value
$1.58 Million
Previous $921,000 39.63%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$67.27 - $86.96 $110,053 - $142,266
1,636 Added 12.09%
15,165 $1.29 Million
Q2 2025

Aug 13, 2025

BUY
$55.17 - $71.22 $746,394 - $963,535
13,529 New
13,529 $921,000
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $5.03 Million - $5.75 Million
87,146 New
87,146 $5.03 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.